PT3532470T - Derivados de oxazol para uso como inibidores de irak e método para a sua preparação - Google Patents

Derivados de oxazol para uso como inibidores de irak e método para a sua preparação

Info

Publication number
PT3532470T
PT3532470T PT177974953T PT17797495T PT3532470T PT 3532470 T PT3532470 T PT 3532470T PT 177974953 T PT177974953 T PT 177974953T PT 17797495 T PT17797495 T PT 17797495T PT 3532470 T PT3532470 T PT 3532470T
Authority
PT
Portugal
Prior art keywords
preparation
oxazole derivatives
irak inhibitors
irak
inhibitors
Prior art date
Application number
PT177974953T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of PT3532470T publication Critical patent/PT3532470T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT177974953T 2016-10-26 2017-10-25 Derivados de oxazol para uso como inibidores de irak e método para a sua preparação PT3532470T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662413217P 2016-10-26 2016-10-26

Publications (1)

Publication Number Publication Date
PT3532470T true PT3532470T (pt) 2023-02-28

Family

ID=60302473

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177974953T PT3532470T (pt) 2016-10-26 2017-10-25 Derivados de oxazol para uso como inibidores de irak e método para a sua preparação

Country Status (9)

Country Link
US (4) US10370367B2 (https=)
EP (1) EP3532470B1 (https=)
JP (2) JP7170634B2 (https=)
CN (1) CN110099899B (https=)
CA (1) CA3041587A1 (https=)
DK (1) DK3532470T3 (https=)
ES (1) ES2939232T3 (https=)
PT (1) PT3532470T (https=)
WO (1) WO2018089199A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110862375B (zh) * 2018-08-27 2022-10-25 深圳铂立健医药有限公司 吡唑化合物及其药物组合物和应用
BR112022001418A2 (pt) * 2019-08-08 2022-06-07 Rigel Pharmaceuticals Inc Compostos e método para tratar a síndrome de liberação de citocinas
CN121159524A (zh) * 2019-08-30 2025-12-19 里格尔药品股份有限公司 吡唑化合物,其配制品以及使用所述化合物和/或配制品的方法
JP2025513716A (ja) * 2022-03-23 2025-04-30 ライジェル・ファーマシューティカルズ・インコーポレイテッド Irak阻害剤としてのピリミド-2-イル-ピラゾール化合物
CN121270516A (zh) * 2024-07-03 2026-01-06 科辉智药(深圳)新药研究中心有限公司 一种irak抑制剂化合物的晶型及其制备方法和应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921475A (en) 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US5087240A (en) 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US4738851A (en) 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US5163899A (en) 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US4882150A (en) 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5521222A (en) 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
EP0431519B1 (en) 1989-12-04 1994-06-15 G.D. Searle & Co. System for transdermal albuterol administration
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
ATE141502T1 (de) 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
US5352456A (en) 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
DE69228827T2 (de) 1991-12-18 1999-10-21 Minnesota Mining And Mfg. Co., Saint Paul Mehrschichtige sperrstrukturen
EP0553769B1 (de) 1992-01-29 1996-01-03 FRANZ VÖLKL GmbH & CO. SKI UND TENNIS SPORTARTIKELFABRIK KG Ballspielschläger, insbesondere Tennisschläger
IL114193A (en) 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
IT1283911B1 (it) 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6197934B1 (en) 1998-05-22 2001-03-06 Collagenesis, Inc. Compound delivery using rapidly dissolving collagen film
US20100160324A1 (en) 2004-12-30 2010-06-24 Astex Therapeutics Limited Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
JP2012254939A (ja) 2009-10-07 2012-12-27 Astellas Pharma Inc オキサゾール化合物
CA2964982C (en) 2014-11-20 2022-07-05 Merck Patent Gmbh Heteroaryl compounds as irak inhibitors and uses thereof
EA039043B1 (ru) * 2015-04-22 2021-11-25 Райджел Фармасьютикалз, Инк. Пиразольные соединения и способ получения и применения данных соединений
JP2019196309A (ja) * 2016-09-15 2019-11-14 武田薬品工業株式会社 複素環化合物

Also Published As

Publication number Publication date
CN110099899B (zh) 2024-01-02
CA3041587A1 (en) 2018-05-17
US20190300518A1 (en) 2019-10-03
DK3532470T3 (da) 2023-02-20
EP3532470B1 (en) 2022-12-07
US10370367B2 (en) 2019-08-06
JP7379640B2 (ja) 2023-11-14
JP7170634B2 (ja) 2022-11-14
US20180111923A1 (en) 2018-04-26
US20210179601A1 (en) 2021-06-17
JP2023011795A (ja) 2023-01-24
US20230062818A1 (en) 2023-03-02
ES2939232T3 (es) 2023-04-20
EP3532470A1 (en) 2019-09-04
WO2018089199A1 (en) 2018-05-17
US11993594B2 (en) 2024-05-28
CN110099899A (zh) 2019-08-06
JP2019537577A (ja) 2019-12-26
US11492349B2 (en) 2022-11-08
US10941140B2 (en) 2021-03-09

Similar Documents

Publication Publication Date Title
IL259801A (en) ezh2 inhibitors and methods of using them
IL248158B (en) Conjugated bicyclic substances containing aryl or heteroaryl errors and their use as irak4 inhibitors
GB201514756D0 (en) Compound and method of use
EP3377070A4 (en) COMPOUNDS AND METHOD FOR THEIR USE
GB201514760D0 (en) Compounds and method of use
GB201609786D0 (en) Compounds and method of use
IL257283A (en) Chiral phosphoramidates and their history
EP3272746A4 (en) Salts of quinazoline derivative and method for preparing same
EP3350196C0 (en) CARBORANE COMPOUNDS AND METHODS OF USE THEREOF
PT3532470T (pt) Derivados de oxazol para uso como inibidores de irak e método para a sua preparação
EP3130340A4 (en) Isoacteoside derivative and preparation method and use thereof
SG11201605915WA (en) Furo-3-carboxamide derivatives and methods of use
ZA201705530B (en) 6-morpholinyl-2-pyrazolyl-9h-purine derivatives and their use as pi3k inhibitors
PL3362450T3 (pl) N1 i n7-podstawione pochodne sybiriliny oraz ich zastosowania jako inhibitory nekroptozy komórkowej
IL261645A (en) History of dioxo-hexahydroisoindolyl and their use as cyclophilin inhibitors
EP3253388A4 (en) A method of treatment and compounds for use therein
EP3216791A4 (en) Polymorphic substance of yonkenafil hydrochloride, preparation method therefor, and composition and use thereof
EP3100734A4 (en) Use of camptothecin derivative in preparing pharmaceutical used for treating multiple myeloma
IL246835A0 (en) Improved process for the preparation of trazodone and its hydrochloride salt
PT3268356T (pt) Compostos heterocíclicos e métodos para a sua utilização
PL3000821T3 (pl) Pochodne pseudofaktyny, sposób otrzymywania pochodnych pseudofaktyny oraz ich zastosowanie
GB2541786B (en) Jig and method of use thereof
EP3223613A4 (en) 4-fluoro-thio-containing inhibitors of app2, compositions thereof and method of use
IL261644A (en) Oxalyl derivatives and their use as cyclophilin inhibitors
AU2015903010A0 (en) Heterocyclic Compounds and Methods for their Use